Anat Biol Anthropol.  2023 Sep;36(3):103-110. 10.11637/aba.2023.36.3.103.

Anti-proliferative Profiling of 6,000 Representative Compounds from the Korean Chemical Bank Diversified Compound Library in De-differentiated Schwann Cells

Affiliations
  • 1Department of Anatomy and Neurobiology, College of Medicine, Kyung Hee University, Seoul, Korea
  • 2Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea
  • 3Department of Precision Medicine, Graduate School, Kyung Hee University, Seoul, Korea
  • 4Department of Pharmacology, College of Medicine, Kyung Hee University, Seoul, Korea
  • 5Department of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, Seoul, Korea
  • 6Department of Biochemistry and Molecular Biology, College of Medicine, Kyung Hee University, Seoul, Korea
  • 7Department of Anatomy and Cell Biology, College of Medicine, Dong-A University, Busan, Korea

Abstract

Early effective in vitro profiling using a vast collection of compounds is crucial to identify hits from large-scale drug screening to find novel therapeutic targets. The usage of molecules with distinct structural properties enhances the possibility of finding fascinating leads and compounds with various biological functions. This study aimed to find effective structures for inhibiting the proliferation of de-differentiated Schwann cells. In this study, we investigated the anti-proliferative effect of 6,000 novel compounds from the Korean Chemical Bank Diversified Compound Library (KCB-DCL) against in vitro de-differentiated Schwann cells at a single dose concentration of 30 μM. Their physiochemical properties, as well as hit rates, molecular targets associated with Schwann cell proliferation, such as proto-oncogene tyrosine-protein kinase Src (SRC), and docking of the selected leads, were assessed. We identified 1,420 hits (23.66%) with an impact on cell viability among 6,000 novel diversified compounds. Ten potential leads (a-j) were chosen from the hits and subjected to docking analysis. Compound e showed the best selectivity toward SRC and had a greater binding affinity ( - 10.7 kcal/mol) than the well-known SRC inhibitor dasatinib ( - 7.5 Kcal/mol). These results can provide a foundation for the early stages of drug discovery for the development of novel modulators aimed at SRC receptor proteins in Schwann cells to treat peripheral neurodegenerative diseases.

Keyword

Korean Chemical Bank Diversified Compound Library (KCB-DCL); Anti-proliferative; Schwann cells; Peripheral nerve degeneration; SRC
Full Text Links
  • ABA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr